Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 39
2007 65
2008 75
2009 55
2010 5
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Results by year
Filters applied: . Clear all
Page 1
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D. de Bono JS, et al. Clin Cancer Res. 2008 Oct 1;14(19):6302-9. doi: 10.1158/1078-0432.CCR-08-0872. Clin Cancer Res. 2008. PMID: 18829513 Free article.
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.
Attard G, Reid AH, Yap TA, Raynaud F, Dowsett M, Settatree S, Barrett M, Parker C, Martins V, Folkerd E, Clark J, Cooper CS, Kaye SB, Dearnaley D, Lee G, de Bono JS. Attard G, et al. J Clin Oncol. 2008 Oct 1;26(28):4563-71. doi: 10.1200/JCO.2007.15.9749. Epub 2008 Jul 21. J Clin Oncol. 2008. PMID: 18645193 Clinical Trial.
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.
Parker C, Sydes MR, Catton C, Kynaston H, Logue J, Murphy C, Morgan RC, Mellon K, Morash C, Parulekar W, Parmar MK, Payne H, Savage C, Stansfeld J, Clarke NW; (RADICALS Trial Management Group). Parker C, et al. BJU Int. 2007 Jun;99(6):1376-9. doi: 10.1111/j.1464-410X.2007.06844.x. Epub 2007 Apr 8. BJU Int. 2007. PMID: 17428247 Free article. Clinical Trial. No abstract available.
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).
Syndikus I, Morgan RC, Sydes MR, Graham JD, Dearnaley DP; MRC RT01 collaborators. Syndikus I, et al. Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):773-83. doi: 10.1016/j.ijrobp.2009.05.052. Epub 2009 Oct 14. Int J Radiat Oncol Biol Phys. 2010. PMID: 19836155 Free PMC article. Clinical Trial.
Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
Mason MD, Sydes MR, Glaholm J, Langley RE, Huddart RA, Sokal M, Stott M, Robinson AC, James ND, Parmar MK, Dearnaley DP; Medical Research Council PR04 Collaborators. Mason MD, et al. J Natl Cancer Inst. 2007 May 16;99(10):765-76. doi: 10.1093/jnci/djk178. J Natl Cancer Inst. 2007. PMID: 17505072 Clinical Trial.
Mesenchymal mechanisms in prostate organogenesis.
Thomson AA. Thomson AA. Differentiation. 2008 Jul;76(6):587-98. doi: 10.1111/j.1432-0436.2008.00296.x. Differentiation. 2008. PMID: 18752494 Review.
Prostate development and pathogenesis.
Thomson AA, Cunha GR, Marker PC. Thomson AA, et al. Differentiation. 2008 Jul;76(6):559-64. doi: 10.1111/j.1432-0436.2008.00303.x. Differentiation. 2008. PMID: 18752493 No abstract available.
Radiosensitivity, radiogenomics and RAPPER.
Burnet NG, Elliott RM, Dunning A, West CM. Burnet NG, et al. Clin Oncol (R Coll Radiol). 2006 Sep;18(7):525-8. doi: 10.1016/j.clon.2006.05.007. Clin Oncol (R Coll Radiol). 2006. PMID: 16969982 No abstract available.
The relevance of a hypoxic tumour microenvironment in prostate cancer.
Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, Riddick AC. Stewart GD, et al. BJU Int. 2010 Jan;105(1):8-13. doi: 10.1111/j.1464-410X.2009.08921.x. Epub 2009 Nov 4. BJU Int. 2010. PMID: 19889065 Free article. Review.
207 results
Jump to page
Feedback